Oxana Beskrovnaya, Chief Scientific Officer at Dyne Therapeutics, Inc. (DYN), sold 4,322 shares at $31.89 ($138K) on 2024-09-11, disclosed to the SEC on 2024-09-11.
Scheduled sale ($138k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.89 | 2,161 | $69K | 50.0% |
| 2 | $31.89 | 2,161 | $69K | 50.0% |
| Total | $31.89 avg | 4,322 | $138K | 100% |
| Filing → |
| DYN | SELL | 2025-02-25 | $36K | — | Filing → |
| DYN | SELL | 2024-12-11 | $131K | — | Filing → |
| DYN | SELL | 2024-11-18 | $161K | — | Filing → |